{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:02:08Z","timestamp":1790373728997,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA255323"],"award-info":[{"award-number":["R01CA255323"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08CA272960-02"],"award-info":[{"award-number":["K08CA272960-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Approximately 5% of renal cell carcinoma (RCC) occurs in the setting of a hereditary RCC syndrome, but accurate phenotype and cancer risk estimates remain limited by ascertainment bias in reported series.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 32\u00a0728 cancer patients who underwent paired tumor-normal sequencing with MSK-IMPACT for germline pathogenic variants (PVs) in RCC hereditary syndrome genes VHL, FLCN, BAP1, MET, SDHB, FH, and proposed RCC risk variants MITF E318K and FH K477dup. We integrated clinical, tumor immunohistochemistry, and genomic data. We performed burden testing across tumor types and, using case-control analysis, validated novel gene-cancer associations with UK Biobank data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Germline PVs diagnostic of hereditary RCC syndromes were identified in 109 of 32\u00a0728 patients (0.33%), including 3.6% of RCC cases. Only 61.5% of carriers met clinical criteria for their syndromes and most patients were undiagnosed prior to testing. Using burden testing, we confirm and suggest novel cancer associations, including BAP1 PVs in hepatobiliary cancers and FLCN in colorectal cancer. We independently validated in the UK Biobank the association of FLCN and colorectal cancer, but analysis of BAP1 and hepatobiliary was limited by small numbers. Tumor analyses demonstrated biallelic inactivation in syndromic tumors and supported pathogenic roles for BAP1 in hepatobiliary cancers and FLCN in colorectal cancers. The FH K477dup PV appears to lack association with RCC risk and there was weak evidence for association of MITF E318K.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Using large, unselected pan-cancer cohorts and integrated tumor and genomic analysis can help refine the phenotype of rare cancer predisposition syndromes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djag290","type":"journal-article","created":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T11:34:06Z","timestamp":1787484846000},"source":"Crossref","is-referenced-by-count":0,"title":["Expanding the phenotype of hereditary renal cell carcinoma syndromes: implications for surveillance and management"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4786-7408","authenticated-orcid":false,"given":"Maria","family":"I Carlo","sequence":"first","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6365-1888","authenticated-orcid":false,"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Ravichandran","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1465-2934","authenticated-orcid":false,"given":"Nikita","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5042-5651","authenticated-orcid":false,"given":"Yelena","family":"Kemel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Zong","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Latham","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2424-4635","authenticated-orcid":false,"given":"Darren","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H","family":"Voss","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritesh","family":"Kotecha","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsofia K","family":"Stadler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E","family":"Robson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miika","family":"Mehine","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1108-4919","authenticated-orcid":false,"given":"Chaitanya","family":"Bandlamudi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4154-0567","authenticated-orcid":false,"given":"Diana","family":"Mandelker","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Bolton","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Medicine, Washington University in St. Louis , Saint Louis, MO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semanti","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2180-2032","authenticated-orcid":false,"given":"Kenneth","family":"Offit","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Motzer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"2026092517461951400_djag290-B1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.eururo.2019.06.015","article-title":"Familial kidney cancer: implications of new syndromes and molecular insights","volume":"76","author":"Carlo","year":"2019","journal-title":"Eur Urol"},{"key":"2026092517461951400_djag290-B2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"2026092517461951400_djag290-B3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00439-013-1331-2","article-title":"Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease","volume":"132","author":"Cooper","year":"2013","journal-title":"Hum Genet"},{"key":"2026092517461951400_djag290-B4","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"2026092517461951400_djag290-B5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","article-title":"Pathogenic germline variants in 10,389 adult cancers","volume":"173","author":"Huang","year":"2018","journal-title":"Cell"},{"key":"2026092517461951400_djag290-B6","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.gim.2022.04.017","article-title":"The gene curation coalition: a global effort to harmonize gene-disease evidence resources","volume":"24","author":"DiStefano","year":"2022","journal-title":"Genet Med"},{"key":"2026092517461951400_djag290-B7","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaoncol.2018.1986","article-title":"Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma","volume":"4","author":"Carlo","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026092517461951400_djag290-B8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41588-021-00949-1","article-title":"The context-specific role of germline pathogenicity in tumorigenesis","volume":"53","author":"Srinivasan","year":"2021","journal-title":"Nat Genet"},{"key":"2026092517461951400_djag290-B9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12920-017-0271-4","article-title":"Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing","volume":"10","author":"Cheng","year":"2017","journal-title":"BMC Med Genomics"},{"key":"2026092517461951400_djag290-B10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2026092517461951400_djag290-B11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"2026092517461951400_djag290-B12","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026092517461951400_djag290-B13","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"2026092517461951400_djag290-B14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1158\/2159-8290.CD-23-0467","article-title":"Quantifying the expanding landscape of clinical actionability for patients with cancer","volume":"14","author":"Suehnholz","year":"2024","journal-title":"Cancer Discov"},{"key":"2026092517461951400_djag290-B15","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/humu.24268","article-title":"Fumarate hydratase (FH) c.1431_1433dupAAA (p.Lys477dup) variant is not associated with FH protein deficiency and increased 2SC in two separate patients with renal neoplasia","volume":"42","author":"Gupta","year":"2021","journal-title":"Hum Mutat"},{"key":"2026092517461951400_djag290-B16","volume-title":"GeneReviews","author":"Sattler","year":"1993"},{"key":"2026092517461951400_djag290-B17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s42255-022-00593-x","article-title":"Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome","volume":"4","author":"Li","year":"2022","journal-title":"Nat Metab"},{"key":"2026092517461951400_djag290-B18","doi-asserted-by":"publisher","first-page":"104359","DOI":"10.1016\/j.ejmg.2021.104359","article-title":"Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: an integrated evaluation of germline and somatic genomic results","volume":"64","author":"Rana","year":"2021","journal-title":"Eur J Med Genet"},{"key":"2026092517461951400_djag290-B19","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cncr.32740","article-title":"Germline alterations in patients with biliary tract cancers: a spectrum of significant and previously underappreciated findings","volume":"126","author":"Maynard","year":"2020","journal-title":"Cancer"},{"key":"2026092517461951400_djag290-B20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/gcc.22129","article-title":"Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases","volume":"53","author":"Pilarski","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"2026092517461951400_djag290-B21","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide","volume":"110","author":"Walpole","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"2026092517461951400_djag290-B22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.6004\/jnccn.2024.0008","article-title":"NCCN guidelines insights: kidney cancer, version 2.2024","volume":"22","author":"Motzer","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"2026092517461951400_djag290-B23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-13-0111","article-title":"A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma","volume":"11","author":"Farley","year":"2013","journal-title":"Mol Cancer Res"},{"key":"2026092517461951400_djag290-B24","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"2026092517461951400_djag290-B25","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"key":"2026092517461951400_djag290-B26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40364-015-0040-5","article-title":"BAP1 hereditary cancer predisposition syndrome: a case report and review of literature","volume":"3","author":"Klebe","year":"2015","journal-title":"Biomark Res"},{"key":"2026092517461951400_djag290-B27","doi-asserted-by":"publisher","first-page":"721712","DOI":"10.3389\/fonc.2021.721712","article-title":"Germline BAP1 mutation in a family with multi-generational meningioma with rhabdoid features: a case series and literature review","volume":"11","author":"Prasad","year":"2021","journal-title":"Front Oncol"},{"key":"2026092517461951400_djag290-B28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11060-026-05445-2","article-title":"High frequency and unique subtypes of meningioma in patients with BAP1 tumor predisposition syndrome","volume":"176","author":"Ramsey","year":"2026","journal-title":"J Neurooncol"},{"key":"2026092517461951400_djag290-B29","doi-asserted-by":"publisher","first-page":"e2491","DOI":"10.1097\/MD.0000000000002491","article-title":"Loss of BAP1 expression occurs frequently in intrahepatic cholangiocarcinoma","volume":"95","author":"Andrici","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2026092517461951400_djag290-B30","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles","volume":"18","author":"Farshidfar","year":"2017","journal-title":"Cell Rep"},{"key":"2026092517461951400_djag290-B31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10689-013-9660-9","article-title":"Pulmonary manifestations of Birt-Hogg-Dube syndrome","volume":"12","author":"Gupta","year":"2013","journal-title":"Fam Cancer"},{"key":"2026092517461951400_djag290-B32","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.gim.2022.05.006","article-title":"Frequency of truncating FLCN variants and Birt-Hogg-Dube-associated phenotypes in a health care system population","volume":"24","author":"Savatt","year":"2022","journal-title":"Genet Med"},{"key":"2026092517461951400_djag290-B33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jmg.2009.073304","article-title":"Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer","volume":"47","author":"Nahorski","year":"2010","journal-title":"J Med Genet"},{"key":"2026092517461951400_djag290-B34","first-page":"393","article-title":"Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome","volume":"11","author":"Zbar","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026092517461951400_djag290-B35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejca.2021.04.013","article-title":"Colorectal cancer risk in families with Birt-Hogg-Dube syndrome increased","volume":"151","author":"Sattler","year":"2021","journal-title":"Eur J Cancer"},{"key":"2026092517461951400_djag290-B36","doi-asserted-by":"publisher","first-page":"2184153","DOI":"10.1080\/15384047.2023.2184153","article-title":"Colon adenocarcinoma and Birt-Hogg-Dube syndrome in a young patient: case report and exploration of pathologic implications","volume":"24","author":"Jirka","year":"2023","journal-title":"Cancer Biol Ther"},{"key":"2026092517461951400_djag290-B37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-024-07769-3","article-title":"Prognostic genome and transcriptome signatures in colorectal cancers","volume":"633","author":"Nunes","year":"2024","journal-title":"Nature"},{"key":"2026092517461951400_djag290-B38","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1101\/gad.324657.119","article-title":"MITF-the first 25 years","volume":"33","author":"Goding","year":"2019","journal-title":"Genes Dev"},{"key":"2026092517461951400_djag290-B39","doi-asserted-by":"publisher","first-page":"17051","DOI":"10.1038\/s41598-020-74237-z","article-title":"Cancer risks associated with the germline MITF(E318K) variant","volume":"10","author":"Guhan","year":"2020","journal-title":"Sci Rep"},{"key":"2026092517461951400_djag290-B40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000443311","article-title":"The microphthalmia-associated transcription factor p.E318K mutation does not play a major role in sporadic renal cell tumors from Caucasian patients","volume":"83","author":"Stoehr","year":"2016","journal-title":"Pathobiology"},{"key":"2026092517461951400_djag290-B41","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1093\/hmg\/ddac089","article-title":"Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases","volume":"31","author":"Yngvadottir","year":"2022","journal-title":"Hum Mol Genet"},{"key":"2026092517461951400_djag290-B42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/humu.23900","article-title":"Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma","volume":"41","author":"Zhang","year":"2020","journal-title":"Hum Mutat"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag290\/70770721\/djag290.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag290\/70770721\/djag290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:46:24Z","timestamp":1790372784000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article\/doi\/10.1093\/jnci\/djag290\/8769500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":42,"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag290","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"djag290"}}